Cencora, Inc.
CORAPI behind this page
COR FY 2025 request
Playground key active
/api/financials?ticker=COR&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 321,332,819 | 293,958,599 | +9.3% |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Alliance Healthcare | 24,394,833 | 23,061,721 | +5.8% |
| International Healthcare Solutions · Operating Segments | 30,366,323 | 28,627,542 | +6.1% |
| International Healthcare Solutions · Other Healthcare Solutions | 5,971,490 | 5,565,821 | +7.3% |
| U.S. Healthcare Solutions · Animal Health | 5,694,517 | 5,365,518 | +6.1% |
| U.S. Healthcare Solutions · Human Health | 285,287,506 | 259,973,909 | +9.7% |
| U.S. Healthcare Solutions · Operating Segments | 290,982,023 | 265,339,427 | +9.7% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -15,527 | -8,370 | -85.5% |
| Cost of Revenue | 309,854,280 | 284,048,570 | +9.1% |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 27,050,982 | 25,306,564 | +6.9% |
| U.S. Healthcare Solutions · Operating Segments | 283,076,597 | 258,916,313 | +9.3% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -9,622 | -5,322 | -80.8% |
| Operating Segments | 310,117,957 | 284,217,555 | +9.1% |
| Gross Profit | 11,478,539 | 9,910,029 | +15.8% |
| Selling, General & Administrative | 6,493,842 | 5,661,106 | +14.7% |
Show Nature Of Expense breakouts |
|||
| Shipping And Handling | 1,294.4 | 1,265.7 | +2.3% |
| Depreciation Nonproduction | 494,141 | 428,500 | +15.3% |
| Amortization Of Intangible Assets | 556,934 | 663,474 | -16.1% |
| Litigation Settlement Expense | 60,671 | 227,070 | -73.3% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 60,671 | 227,070 | -73.3% |
| Business Combination Acquisition Related Costs | 291,044 | 103,001 | +182.6% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 291,044 | 103,001 | +182.6% |
Show Business Acquisition breakouts |
|||
| RCA | 65.1 | — | — |
| Restructuring Charges | 229,422 | 233,629 | -1.8% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 229,422 | 233,629 | -1.8% |
| Goodwill Impairment Loss | 723,884 | 418,000 | +73.2% |
Show Business Segments breakouts |
|||
| International Healthcare Solutions | 723,884 | 418,000 | +73.2% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 723,884 | 418,000 | +73.2% |
| Operating Income | 2,628,601 | 2,175,249 | +20.8% |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 648,274 | 713,379 | -9.1% |
| U.S. Healthcare Solutions · Operating Segments | 3,574,699 | 2,934,877 | +21.8% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 4,222,973 | 3,648,256 | +15.8% |
| Non-Operating Income (Expense) | 78,717 | 14,283 | +451.1% |
| Interest Income Expense Nonoperating Net | 291,548 | 156,991 | +85.7% |
| Income Before Taxes | 2,258,336 | 2,003,975 | +12.7% |
| Income Tax Expense (Benefit) | 690,522 | 484,702 | +42.5% |
| Net Income | 1,567,814 | 1,519,273 | +3.2% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 13,645 | 10,153 | +34.4% |
| Retained Earnings | 1,554,169 | 1,509,120 | +3.0% |
| Net Income Loss Attributable To Noncontrolling Interest | -13,645 | -10,153 | -34.4% |
| Net Income | 1,554,169 | 1,509,120 | +3.0% |
| EPS (Basic) | 8.02 | 7.6 | +5.5% |
| EPS (Diluted) | 7.96 | 7.53 | +5.7% |
| Wtd Avg Shares (Basic) | 193,820 | 198,503 | -2.4% |
| Wtd Avg Shares (Diluted) | 195,214 | 200,284 | -2.5% |
| Operating Expenses | 6,991,889 | 6,092,788 | +14.8% |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 2,667,067 | 2,607,599 | +2.3% |
| U.S. Healthcare Solutions · Operating Segments | 4,330,727 | 3,488,237 | +24.2% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -5,905 | -3,048 | -93.7% |
| Comprehensive Income | 1,641,909 | 1,922,609 | -14.6% |
| Other Expenses | 5,574 | 33,592 | -83.4% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 4,356,138 | 3,132,648 | +39.1% |
| Accounts Receivable | 25,225,299 | 23,871,815 | +5.7% |
| Inventory | 20,492,480 | 18,998,833 | +7.9% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 303,480 | 259,299 | +17.0% |
| Contract With Customer Asset Gross Current | 1,625,817 | 1,175,871 | +38.3% |
| Prepaid Expenses & Other Current Assets | 539,339 | 538,646 | +0.1% |
| Total Current Assets | 52,239,073 | 47,717,813 | +9.5% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 2,539,076 | 2,181,410 | +16.4% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 65,410 | 49,869 | +31.2% |
| Goodwill | 13,676,520 | 9,318,027 | +46.8% |
Show Business Segments breakouts |
|||
| International Healthcare Solutions | 2,571,530 | 3,109,505 | -17.3% |
| U.S. Healthcare Solutions | 11,104,990 | 6,208,522 | +78.9% |
| Deferred Tax Assets | 208,810 | 246,348 | -15.2% |
| Other Non-Current Assets | 4,152,452 | 3,637,023 | +14.2% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 99,519 | 83,765 | +18.8% |
| Total Assets | 76,590,112 | 67,101,667 | +14.1% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 909,806 | 814,673 | +11.7% |
| Operating Lease Right-of-Use Assets | 1,548,478 | 1,141,622 | +35.6% |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 3,390,428 | 3,554,783 | -4.6% |
| Trade names and other | 366,753 | 429,263 | -14.6% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 3,774,181 | 4,001,046 | -5.7% |
| Current Liabilities | |||
| Accounts Payable | 54,719,761 | 50,942,162 | +7.4% |
| Accrued Liabilities | 2,982,993 | 2,758,560 | +8.1% |
| Debt Current | 117,785 | 576,331 | -79.6% |
| Total Current Liabilities | 57,820,539 | 54,277,053 | +6.5% |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Alliance Healthcare debt | 1,424 | 286 | +397.9% |
| Nonrecourse debt | 116,361 | 76,307 | +52.5% |
| Non-Current Liabilities | |||
| Long-Term Debt | 7,542,988 | 3,811,745 | +97.9% |
| Accrued Income Taxes Noncurrent | 337,631 | 291,796 | +15.7% |
| Deferred Tax Liabilities | 1,620,724 | 1,643,746 | -1.4% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 11,986 | 19,227 | -37.7% |
| Litigation Reserve Noncurrent | 3,881,283 | 4,296,902 | -9.7% |
| Other Non-Current Liabilities | 3,639,862 | 1,993,683 | +82.6% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 75,132 | 61,690 | +21.8% |
| Long-Term Debt | 7,660,773 | 4,388,076 | +74.6% |
Show Debt Instrument breakouts |
|||
| $1,000,000, 2.700% senior notes due 2031 | 993,838 | 992,718 | +0.1% |
| $500,000, 2.800% senior notes due 2030 | 497,174 | 496,564 | +0.1% |
| $500,000, 4.250% senior notes due 2045 | 495,792 | 495,574 | 0.0% |
| $500,000, 4.300% senior notes due 2047 | 494,088 | 493,821 | +0.1% |
| $500,000, 4.625% senior notes due 2027 | 497,309 | — | — |
| $500,000, 5.125% senior notes due 2034 | 495,104 | 494,514 | +0.1% |
| $600,000, 4.850% senior notes due 2029 | 596,603 | — | — |
| $700,000, 5.150% senior notes due 2035 | 694,909 | — | — |
| $750,000, 3.450% senior notes due 2027 | 748,150 | 747,308 | +0.1% |
| Alliance Healthcare debt | 1,424 | 286 | +397.9% |
| Nonrecourse debt | 181,751 | 167,553 | +8.5% |
| Term loan due in 2027 | 799,043 | — | — |
| €500,000, 2.875% senior notes due 2028 | 583,903 | — | — |
| €500,000, 3.625% senior notes due 2032 | 581,685 | — | — |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 65,390 | 91,246 | -28.3% |
| Operating Lease Liabilities | 1,416,633 | 1,029,978 | +37.5% |
| Total Liabilities (Q) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 690,128 | 612,269 | +12.7% |
| Other Liabilities | |||
| Minority Interest | 239,066 | 140,804 | +69.8% |
| Stockholders' Equity | |||
| Common Stock | 2,974 | 2,962 | +0.4% |
| Additional Paid In Capital Common Stock | 6,204,302 | 6,030,790 | +2.9% |
| Retained Earnings | 6,534,227 | 5,417,139 | +20.6% |
| Accumulated Other Comprehensive Income | -901,378 | -989,118 | +8.9% |
| Treasury Stock Common Value | -10,332,106 | -9,815,835 | -5.3% |
| Total Stockholders' Equity | 1,508,019 | 645,938 | +133.5% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -901,378 | -989,118 | +8.9% |
| Accumulated Translation Adjustment | -903,078 | -988,484 | +8.6% |
| Other, net | 1,700 | -634 | +368.1% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1,747,085 | 786,742 | +122.1% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -901,378 | -989,118 | +8.9% |
| Additional Paid In Capital | 6,204,302 | 6,030,790 | +2.9% |
| Common Stock | 2,974 | 2,962 | +0.4% |
| Noncontrolling Interest | 239,066 | 140,804 | +69.8% |
| Retained Earnings | 6,534,227 | 5,417,139 | +20.6% |
| Treasury Stock Common | -10,332,106 | -9,815,835 | -5.3% |
| Total Liabilities & Equity | 76,590,112 | 67,101,667 | +14.1% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation | 501,310 | 448,200 | +11.8% |
| Adjustment For Amortization | 567,106 | 670,642 | -15.4% |
| Provision For Doubtful Accounts | 63,306 | 40,834 | +55.0% |
| Deferred Income Taxes | 59,864 | -102,324 | +158.5% |
| Stock-Based Compensation | 147,963 | 147,998 | -0.0% |
| Inventory L I F O Reserve Period Charge | -76,875 | -52,168 | -47.4% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | -76,876 | -52,168 | -47.4% |
| Asset Impairment Charges | 837,378 | 418,000 | +100.3% |
| Gain Loss On Sale Of Business | 35,539 | — | — |
| Inflationary Accounting Impact | 55,519 | 55,309 | +0.4% |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 (FY) | — | — | — |
Show Business Acquisition breakouts |
|||
| RCA · Equity units | 121.7 | — | — |
Show Contingent Consideration By Type breakouts |
|||
| Equity units | 121,666 | — | — |
| Predefined business objective | 19,550 | — | — |
| Equity Investment Remeasurement Gain Loss | -14,058 | 16,201 | -186.8% |
| Gain Loss On Sale Of Investments | -12,838 | — | — |
| Other Non-Cash Items | -33,548 | 24,032 | -239.6% |
| Change in Accounts Receivable | -1,923,411 | -2,784,339 | +30.9% |
| Change in Inventory | -1,269,429 | -1,479,599 | +14.2% |
| Change in Prepaid & Other Assets | 173,857 | 156,672 | +11.0% |
| Change in Accounts Payable | 3,693,364 | 4,968,093 | -25.7% |
| Increase Decrease In Accrued Liabilities | -21,131 | 148,533 | -114.2% |
| Increase Decrease In Income Taxes Payable And Other Liabilities | -213,724 | -204,517 | -4.5% |
| Increase Decrease In Accrued Estimated Litigation Liability | -404,102 | -506,155 | +20.2% |
| Net Cash from Operations | 3,875,120 | 3,484,685 | +11.2% |
| Depreciation & Amortization | 1,051,075 | 1,091,974 | -3.7% |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 145,445 | 132,999 | +9.4% |
| U.S. Healthcare Solutions · Operating Segments | 352,602 | 298,683 | +18.1% |
| Investing Activities | |||
| Capital Expenditures | -667,981 | -487,173 | -37.1% |
| Payments To Acquire Businesses Net Of Cash Acquired | -4,095,630 | -69,771 | -5770.1% |
| Payments To Acquire Equity Method Investments | -196,242 | -30,430 | -544.9% |
| Payments To Acquire Notes Receivable | -34,814 | -50,000 | +30.4% |
| Other Investing Activities | 17,374 | 19,278 | -9.9% |
| Net Cash from Investing | -4,977,293 | -618,096 | -705.3% |
| Financing Activities | |||
| Proceeds From Issuance Of Debt | 4,508,482 | 688,321 | +555.0% |
| Repayments Of Long Term Debt | -1,280,615 | -662,525 | -93.3% |
| Proceeds From Lines Of Credit | 132,134,224 | 69,703,045 | +89.6% |
| Repayments Of Lines Of Credit | -132,166,423 | -70,114,293 | -88.5% |
| Share Repurchases | -435,471 | -1,491,367 | +70.8% |
| Proceeds From Stock Options Exercised | 29,133 | 37,840 | -23.0% |
| Payments Of Dividends Common Stock | -437,081 | -416,168 | -5.0% |
| Tax Withholding for Share Compensation | -77,783 | -63,500 | -22.5% |
| Proceeds From Payments For Other Financing Activities | -25,352 | -12,347 | -105.3% |
| Net Cash from Financing | 2,249,114 | -2,330,994 | +196.5% |
| Supplemental | |||
| Income Taxes Paid | 571.2 | 603.9 | -5.4% |
| Interest Paid | 356.5 | 250.1 | +42.5% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -50,272 | 9,396 | -635.0% |
| Net Change in Cash | 1,096,669 | 544,991 | +101.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4,394,549 | 3,297,880 | +33.3% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 70,796 | 58,082 | +21.9% |
Values in thousands USD. Source: SEC EDGAR 10-K filing.